Literature DB >> 11356683

Androgen regulates the level and subcellular distribution of the AU-rich ribonucleic acid-binding protein HuR both in vitro and in vivo.

L G Sheflin1, W Zhang, S W Spaulding.   

Abstract

HuR, a member of the ELAV family of AU-rich RNA-binding proteins, is present in a variety of tissues and is directly involved in stabilizing labile AU-rich messenger RNAS: We have found that treating the human HepG2 cell line with 10 nM dihydrotestosterone (DHT) for 48 h decreases the total level of HuR by 75%. DHT decreases both cytosolic and nuclear HuR levels in HepG2 cells, but increases HuR levels in polyribosomes by 325%. In BALB/c mice, HuR levels in the submaxillary salivary gland (SMG) and the kidney display a dramatic sexual dimorphism, but those in the spleen and thyroid do not. DHT (200 microg) causes total HuR levels in female SMG and kidney to fall progressively, whereas, conversely, orchiectomy of males causes HuR levels to rise in these two tissues by 800% and 200%, respectively. As an internal control we probed the same blots for AUF1, a destabilizing AU-binding protein, and confirmed our previous findings showing that the cytosolic p37 isoform of AUF1 shows the opposite responses of cytosolic HuR in the SMG, and that the level of AUF1 in the kidney does not respond to DHT. In polyribosomes from female mouse SMG, HuR levels doubled after 6 h of DHT, but decreased by 80% after 24- and 48-h DHT treatment. Thus, the total level of HuR is regulated in two different androgen-responsive systems, as is the shuttling of HuR between different subcellular compartments. As AUF1 is responsive to androgen in the mouse SMG, but not in the kidney, tissue-specific posttranscriptional regulation of AU-rich messenger RNA metabolism could be mediated in part by differential androgen-dependent regulation of HuR and AUF1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356683     DOI: 10.1210/endo.142.6.8164

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Exon-level expression profiling: a comprehensive transcriptome analysis of oral fluids.

Authors:  Zhanzhi Hu; Bernhard G Zimmermann; Hui Zhou; Jianghua Wang; Bradley S Henson; Weixia Yu; David Elashoff; Guido Krupp; David T Wong
Journal:  Clin Chem       Date:  2008-03-20       Impact factor: 8.327

Review 2.  Cyclooxygenases in hepatocellular carcinoma.

Authors:  Melchiorre Cervello; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

3.  The RNA-Binding Protein ELAVL1 Regulates GnRH Receptor Expression and the Response to GnRH.

Authors:  Tomohiro Terasaka; Taeshin Kim; Hiral Dave; Bhakti Gangapurkar; Dequina A Nicholas; Oscar Muñoz; Eri Terasaka; Danmei Li; Mark A Lawson
Journal:  Endocrinology       Date:  2019-08-01       Impact factor: 4.736

4.  Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation.

Authors:  Henrique J Cardoso; Marília I Figueira; Cátia V Vaz; Tiago M A Carvalho; Luís A Brás; Patrícia A Madureira; Paulo J Oliveira; Vilma A Sardão; Sílvia Socorro
Journal:  Cell Oncol (Dordr)       Date:  2021-01-19       Impact factor: 6.730

5.  Differential recruitment of nuclear receptor coactivators may determine alternative RNA splice site choice in target genes.

Authors:  Didier Auboeuf; Dennis H Dowhan; Yun Kyoung Kang; Kimberly Larkin; Jae Woon Lee; Susan M Berget; Bert W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

Review 6.  Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosis.

Authors:  Jun Wang; Yan Guo; Huili Chu; Yaping Guan; Jingwang Bi; Baocheng Wang
Journal:  Int J Mol Sci       Date:  2013-05-10       Impact factor: 5.923

Review 7.  mRNA Post-Transcriptional Regulation by AU-Rich Element-Binding Proteins in Liver Inflammation and Cancer.

Authors:  Dobrochna Dolicka; Cyril Sobolewski; Marta Correia de Sousa; Monika Gjorgjieva; Michelangelo Foti
Journal:  Int J Mol Sci       Date:  2020-09-11       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.